Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

OBJECTIVE: To evaluate serum tumor markers (STM) as predictive biomarkers in advanced non-small cell lung cancer (NSCLC) treated with chemo-immunotherapy. METHODS: Patients having received platinum-based chemo-(CHT) and PD-1/PD-L1-directed immune checkpoint inhibitor (ICI) combination therapy were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, David, Haslinger, Wolfgang, Akbari, Kaveh, Scala, Mario, Hergan, Benedikt, Asel, Christian, Horner, Andreas, Wass, Romana, Brehm, Elmar, Kaiser, Bernhard, Lamprecht, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755331/
https://www.ncbi.nlm.nih.gov/pubmed/33376433
http://dx.doi.org/10.2147/LCTT.S286228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755331/
https://www.ncbi.nlm.nih.gov/pubmed/33376433
http://dx.doi.org/10.2147/LCTT.S286228

Ejemplares similares